Angion Biomedica Corp. (ANGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.9700 |
| Open | 2.0200 |
| Bid | 1.9500 x 1000 |
| Ask | 2.0300 x 1200 |
| Day's range | 1.9200 - 2.0380 |
| 52-week range | 1.0750 - 15.5580 |
| Volume | |
| Avg. volume | 151,200 |
| Market cap | 58.715M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.0040 |
| Earnings date | 28 Mar 2022 - 01 Apr 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.00 |
- Simply Wall St.
Jay Venkatesan Is The President of Angion Biomedica Corp. (NASDAQ:ANGN) And They Just Picked Up 5.7% More Shares
Potential Angion Biomedica Corp. ( NASDAQ:ANGN ) shareholders may wish to note that the President, Jay Venkatesan...
- Zacks
Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease
Aerie Pharmaceutials (AERI) doses the first patient in a phase III study on its investigational TRMP8 agonist drug for the treatment of dry eye disease.
- Zacks
Athersys (ATHX) Down as Ischemic Stroke Study Fails to Meet Goal
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
© 2022 Yahoo. All rights reserved.
